SecSonar.com

NEXGEL, Inc. (NXGL)

NEXGEL, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

NEXGEL, Inc. (NXGL) is a Medical - Instruments & Supplies company based in US with a market capitalization of $5.6M. Revenue grew 31.5% year-over-year and free cash flow was negative at -$1.4M. This page tracks NXGL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 19 employees · IPO Dec 22, 2021

Valuation

Valuation & price

$0.51 · as of May 17, 2026 · -81.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.25

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.72$1.61$0.50Jul 25Dec 25Jun 26Jul 7, 25$2.64Jul 9, 25$2.72Jul 11, 25$2.69Jul 15, 25$2.51Jul 17, 25$2.39Jul 21, 25$2.39Jul 23, 25$2.52Jul 25, 25$2.36Jul 29, 25$2.36Jul 31, 25$2.25Aug 4, 25$2.60Aug 6, 25$2.54Aug 8, 25$2.69Aug 12, 25$2.71Aug 14, 25$2.23Aug 19, 25$2.39Aug 21, 25$2.22Aug 25, 25$2.36Aug 27, 25$2.34Aug 29, 25$2.46Sep 3, 25$2.30Sep 5, 25$2.22Sep 9, 25$2.34Sep 11, 25$2.47Sep 15, 25$2.57Sep 17, 25$2.50Sep 19, 25$2.60Sep 23, 25$2.47Sep 25, 25$2.40Sep 29, 25$2.42Oct 2, 25$2.43Oct 6, 25$2.54Oct 8, 25$2.71Oct 10, 25$2.57Oct 14, 25$2.58Oct 16, 25$2.36Oct 20, 25$2.58Oct 22, 25$2.61Oct 24, 25$2.59Oct 28, 25$2.56Oct 30, 25$2.49Nov 3, 25$2.35Nov 5, 25$2.37Nov 7, 25$2.48Nov 11, 25$2.28Nov 14, 25$1.91Nov 18, 25$1.78Nov 20, 25$1.62Nov 24, 25$1.58Nov 26, 25$1.82Dec 1, 25$1.66Dec 3, 25$1.60Dec 5, 25$1.58Dec 9, 25$1.53Dec 11, 25$1.84Dec 15, 25$1.59Dec 17, 25$1.89Dec 19, 25$1.62Dec 23, 25$1.56Dec 26, 25$1.53Dec 31, 25$1.61Jan 5, 26$1.77Jan 7, 26$1.72Jan 9, 26$1.65Jan 13, 26$1.67Jan 15, 26$1.74Jan 20, 26$1.54Jan 22, 26$1.57Jan 26, 26$1.60Jan 28, 26$1.59Jan 30, 26$1.42Feb 3, 26$1.23Feb 5, 26$1.21Feb 9, 26$1.29Feb 11, 26$1.40Feb 17, 26$1.30Feb 19, 26$1.25Feb 23, 26$1.19Feb 25, 26$1.11Feb 27, 26$1.15Mar 3, 26$1.08Mar 5, 26$0.98Mar 9, 26$1.13Mar 11, 26$0.82Mar 13, 26$0.83Mar 17, 26$0.82Mar 19, 26$0.78Mar 23, 26$0.72Mar 25, 26$0.68Mar 27, 26$0.66Apr 1, 26$0.62Apr 6, 26$0.65Apr 8, 26$0.64Apr 10, 26$0.57Apr 14, 26$0.59Apr 16, 26$0.64Apr 20, 26$0.64Apr 22, 26$0.65Apr 24, 26$0.65Apr 28, 26$0.61Apr 30, 26$0.59May 4, 26$0.61May 6, 26$0.60May 8, 26$0.59May 12, 26$0.58May 15, 26$0.51May 19, 26$0.61May 21, 26$0.54May 26, 26$0.53May 28, 26$0.60Jun 1, 26$0.59Jun 3, 26$0.59Jun 5, 26$0.56Jun 9, 26$0.58Jun 11, 26$0.59Jun 15, 26$0.54Jun 17, 26$0.61Jun 22, 26$0.61Jun 24, 26$0.54Jun 30, 26$0.50
$0.5052-week range$2.78
Loading valuation history…

Fundamentals

Key fundamentals

$5.6M

Market cap

31.5%

Revenue growth (YoY)

39.5%

Gross margin

-$1.4M

Free cash flow (USD)

$2.8M

Net debt

20.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$2.2MFY 2017$2.0MFY 2018$2.2MFY 2019$717.0KFY 2020$674.0KFY 2021$1.6MFY 2022$2.0MFY 2023$4.1MFY 2024$8.7MFY 2025$11.4M
$2.2M$11.4M

Free cash flow by year

2016 → 2025

FY 2016$-1.3MFY 2017$-784.0KFY 2018$-1.5MFY 2019$-1.8MFY 2020$-2.1MFY 2021$-3.0MFY 2022$-3.1MFY 2023$-3.9MFY 2024$-4.3MFY 2025$-1.4M
-$1.3M-$1.4M

Gross margin by year

2021 → 2025

FY 20210.5%FY 202212.5%FY 20239.2%FY 202431.6%FY 202539.5%
0.5%39.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

5

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 14, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector ResignationJul 2, 2026Filing
  • Insider sellInsider Sell $7KLevy Adam R. · Director, Chief Executive Officer · $6.5KJun 23, 2026Filing
  • 8-K eventInvestor Presentation ReleasedJun 17, 2026Filing
  • Insider sellInsider Sell $2KLevy Adam R. · Director, Chief Executive Officer · $1.8KJun 15, 2026Filing
  • Insider sellInsider Sell $3KLevy Adam R. · Director, Chief Executive Officer · $3.4KJun 9, 2026Filing
  • Insider sellInsider Sell $1KLevy Adam R. · Director, Chief Executive Officer · $1.2KJun 3, 2026Filing
  • Insider sellInsider Sell $8KLevy Adam R. · Director, Chief Executive Officer · $7.8KMay 29, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventDirector AppointmentMay 12, 2026Filing

Questions

Frequently asked questions

What is NEXGEL, Inc.'s market cap?

NEXGEL, Inc. (NXGL) has a market capitalization of $5.6M.

What is NXGL's P/E ratio?

A meaningful P/E ratio is not available for NXGL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NXGL's price-to-book (P/B) ratio?

NXGL trades at 1.25 times book value per share.

Are insiders buying NXGL stock?

SEC Form 4 filings show no open-market insider buys at NEXGEL, Inc. in the last 90 days (5 sells).

Same arena

Related companies in Medical - Instruments & Supplies

LUCY

Innovative Eyewear, Inc.

$4.1M

FEMY

Femasys Inc.

$11.1M

ZJYL

Jin Medical International Ltd.

$17.6M

RVP

Retractable Technologies, Inc.

$20.4M

HBIO

Harvard Bioscience, Inc.

$26.7M

MLSS

Milestone Scientific Inc.

$33.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.